Genomenon announced that it has published the first Cited Variant Reference (CVR)

Genomenon announced that it has published the first Cited Variant Reference (CVR), a comprehensive catalogue of genetic variants cited in the medical literature. The... Read More

BIO2018: Robin Roberts, Diana Ross and Record-breaking Partnering

As BIO celebrates its 25-year anniversary, the upcoming BIO International Convention June 4-7 at the Boston Convention and Exhibition Center will highlight the organization’s... Read More

LifeX™ Health Solutions Platform Opens Headquarters – Announces $2 million Henry L. Hillman Foundation grant

LifeX™, as part of Life Sciences Week 2018, celebrated the opening of its first headquarters, where it will provide expertise and working space to... Read More

Thermo Fisher Scientific Launches Oncomine Childhood Cancer Research Assay and Establishes International Childhood Oncology Network

One in 285 children born in the U.S. this year alone will be diagnosed with cancer before their 20th birthday1, yet, until recently, too... Read More

Nicklaus Children’s Hospital, in collaboration with Rady Children’s Institute for Genomic Medicine and Sanford Health, has launched two genomic medicine research protocols to more effectively diagnose and treat children with unexplained illnesses.

Nicklaus Children’s Hospital, in collaboration with Rady Children’s Institute for Genomic Medicine and Sanford Health, has launched two genomic medicine research protocols to more... Read More

Opdivo Plus Low-Dose Yervoy Combination Reduces the Risk of Progression or Death…

Bristol-Myers Squibb  announced initial results from the pivotal Phase 3 study, CheckMate -227, evaluating the Opdivo (nivolumab) 3 mg/kg plus low-dose Yervoy (ipilimumab, 1... Read More

PierianDx Forms Strategic Partnership with Leading Research and Technical Services Organization RTI International

PierianDx, the leading genomics technology company that enables precision medicine, announced today a strategic partnership with RTI International to help solve the problem of... Read More

CIGNA TO ACQUIRE EXPRESS SCRIPTS FOR $67 BILLION

Cigna Corporation (NYSE: CI) and Express Scripts Holding Company (NASDAQ: ESRX) today announced that they have entered into a definitive agreement whereby Cigna will... Read More

Foundation Medicine Announces 2017 Fourth Quarter and Year-End Results

Foundation Medicine reported financial and operational results for the fourth quarter and year ended December 31, 2017. Highlights for the quarter and year included:... Read More

PierianDx Launches Clinical Genomics Services to Accelerate Precision Medicine

PierianDx, the leading genomics technology company that enables precision medicine, announced today a full range of expanded services to support adoption of the company’s... Read More

2bPrecise and The Innovation Institute to Deliver Robust Pharmacogenomics Platform, GeneFolio, to the Point of Care

2bPrecise®, LLC, and The Innovation Institute announced today that they have entered into an agreement that lays the foundation for 2bPrecise to deliver a... Read More

Allscripts launches industry’s first machine learning EHR

Allscripts Healthcare Solutions (NASDAQ:MDRX) unveiled its new electronic health record (EHR), Avenel™, at the annual HIMSS conference today. Mobile-first and cloud-based, Avenel creates a... Read More

BC Platforms Launches an End-to-end Solution for Precision Medicine Powered by the Microsoft Genomics Service

BC Platforms, a pioneer in genomic data management and analytics, today announces it has launched GeneVision, a new end-to-end Solution for Precision Medicine that... Read More

Baylor Genetics Expands Its Precision Medicine Portfolio With ClariFind.

Baylor Genetics announced the launch of ClariFind, a comprehensive somatic tumor next-generation sequencing test that correlates genomic results with specific drug therapies and clinical... Read More

Atos Transforms Value-based Healthcare with Digital Health Solutions

Atos, a global leader in digital transformation, continues to strengthen its North America digital healthcare portfolio with services that help enable the shift to... Read More

Orion Health Unveils New Predictive Intelligence Using Machine Learning to Help Save Billions in Healthcare Costs

Orion Health™ has announced its machine learning service, Amadeus Intelligence, designed to help the health sector reduce operating costs and improve patient care. Led... Read More

Tempus and NYU School of Medicine Announce New Initiative to Help Improve Outcomes for Pancreatic Cancer Patients

Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, today announced... Read More

Luna DNA Announces Dawn Barry, former Illumina VP, as President

Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced today Dawn... Read More

Clinical Genomics appoints Tadd Lazarus, MD, as Chief Medical Officer

Clinical Genomics, a leading provider of cancer diagnostic solutions and liquid biopsy tests, today announced the appointment of Tadd Lazarus, M.D., as Chief Medical... Read More

Roche and GE enter partnership to develop integrated digital diagnostics platform to improve oncology and critical care treatment

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it has entered into a strategic, long-term partnership with GE Healthcare in order to jointly develop... Read More

Oncologists Can Now Specify Cancer Treatment Options to Score and Rank with CureMatch

CureMatch® will present the new release of PreciGENE™ Personalized Combination Therapy® at Biotech Showcase™ 2018, to be held January 8–10 in San Francisco. Oncologists... Read More

Renowned Scientists Join Rady Children’s Institute for Genomic Medicine Scientific Advisory Board

The Rady Children’s Institute for Genomic Medicine (RCIGM) is pleased to announce that six influential life science researchers have been recruited to serve on... Read More

Patients Can Now Request a OneOme RightMed® Test Through an Independent Provider Network

Precision medicine company OneOme is partnering with PWNHealth to increase patient access to the RightMed® comprehensive test without compromising patient safety. Until now, patients... Read More

Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology

Syapse, a leading precision medicine company, announced today it has entered into a multi-year strategic collaboration with Roche (SIX: RO, ROG; OTCQX: RHHBY) to... Read More

Concert Genetics Completes Growth Financing

Concert Genetics, Inc., has announced it has completed a growth capital financing round with a structured facility led by Deerfield Management. The funds will... Read More

Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA efforts to support more efficient development of targeted therapies

In recent years, the medical community has experienced a shift in the way health care is practiced. Rather than focusing solely on how to... Read More

RowAnalytics, Martinos Center & Envision Genomics Create GIRO Health, a new Flagship Open Initiative in Precision Medicine

RowAnalytics Ltd., the Martinos Center for Biomedical Imaging (Martinos Center) and Envision Genomics Inc. today announced that they are combining their world leading technologies... Read More

University of Cincinnati Cancer Institute Joins Caris Life Sciences’ Precision Oncology Alliance

Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that the University of Cincinnati... Read More

Dr. Aradhana Ghosh Joins Precision Medicine Leader Syapse As Vice President of Oncology

Syapse, a market leader in precision medicine solutions, announced today that Dr. Aradhana Ghosh has joined the company as Vice President of Oncology. An... Read More

Personalized Cancer Medicine Research Spearheaded by CureMatch Co-Founders

CureMatch Co-Founders Igor F. Tsigelny, Ph.D. and Razelle Kurzrock, M.D. along with colleagues from UC San Diego and University of Bergen have authored a... Read More

Closing in on advanced prostate cancer

Xavier Salvatella, ICREA researcher at IRB Barcelona, ​​proposes a new approach to combat prostate tumour cells that have become unresponsive to the treatments currently... Read More

GNS Healthcare Uses Causal AI to Discover Which Multiple Myeloma Patients Will Have Progression Free Survival Benefit from Stem Cell Treatments

GNS Healthcare (GNS), a leading precision medicine company, together with the Multiple Myeloma Research Foundation (MMRF), have discovered a biomarker that identifies which multiple... Read More

Brotman Baty Institute for Precision Medicine Launches in Seattle

Jeffrey and Susan Brotman and Pam and Dan Baty have made a $50 million gift to create the Brotman Baty Institute for Precision Medicine... Read More

Government and life sciences sector agree transformative sector deal

A transformative Sector Deal between the UK life sciences sector and the government has today (Wednesday 6 December) been announced. This draws substantial investment... Read More

Blueprint Genetics CEO – clinical grade genetic testing becoming increasingly available

Blueprint Genetics CEO Tommi Lehtonen believes advances in clinical genetic testing will soon begin to feed into the genetic screening of healthy individuals. Clinical... Read More

XIFIN Announces Next-Generation Revenue Cycle Management with RPM 9 to Help Laboratories Improve Revenue, Patient Engagement and Reporting During Unprecedented Market Disruption

XIFIN, Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, and a Frost & Sullivan’s 2017 North American Revenue Cycle Management... Read More

South Africa’s CPGR to partner with The Sunflower Fund to stimulate medical innovation in Africa through access to high-resolution HLA testing and data aggregation

The Centre for Proteomic and Genomic Research (CPGR) today announced that it has entered into a partnership with The Sunflower Fund (TSF) to make... Read More

Canon BioMedical products now available in Austria, Germany, and Switzerland

Canon BioMedical is pleased to announce our latest geographic expansion into the German-speaking countries of Austria, Germany, and Switzerland. We are working with a... Read More

Philips teams with 3D printing industry leaders 3D Systems and Stratasys

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced agreements with 3D Systems and Stratasys, two global leaders in the... Read More

Definiens broadens Immuno-Oncology Service Offering

With the start of the 32nd Annual Meeting (November 8th-12th) of the Society for Immunotherapy of Cancer (SITC) in National Harbor, MD, Definiens, the... Read More

SeraCare Announces Industry’s First Comprehensive NGS Reference Material for Hematologic Malignancies

SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, is expanding what is already the most... Read More

Patrick Vallance, President, R&D, GSK to become UK Government’s Chief Scientific Adviser

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Dr Patrick Vallance, President, R&D, has informed the Board of his intention to leave the company to... Read More

University Hospital Bonn Announces New Technology To Advance Ability to Diagnose Rare Genetic Diseases in Children

The Institute for Genome Statistics and Bioinformatics, IGSB, and the Institute of Human Genetics, IHG, Bonn, have announced a new initiative to further precision... Read More

Sema4 Appoints Fertility Expert Alan Copperman, MD, as Chief Medical Officer

Sema4, a health information company providing advanced genomic testing, recently announced the appointment of Alan B. Copperman, MD, as Chief Medical Officer. Dr. Copperman... Read More

Personalis Wins New Contract to Sequence >34,000 Whole Human Genomes for the VA’s Million Veteran Program

Personalis, Inc., a provider of advanced genomic sequencing and analytics for immuno-oncology, today announced a new contract with the US Department of Veterans Affairs... Read More

Precision Medicine Meets Single-Cell DNA Analysis with Mission Bio

Mission Bio, Inc., a pioneer in single-cell DNA analysis, recently announced it has secured $10 million in Series A funding. Silicon Valley venture capital... Read More

Natera Chosen for Longitudinal Circulating Tumour DNA Study in Breast Cancer

Natera, Inc., (NASDAQ: NTRA), a global leader in cell-free DNA testing, has entered into a research collaboration with Imperial College London and the University... Read More

PAREXEL and Microsoft Form Cloud Technology Alliance Aimed at Accelerating the Pace of Drug Development

PAREXEL International Corp., a leading global biopharmaceutical services organization, and Microsoft Corp. announced a technology development alliance aimed at driving innovation across the life... Read More

The Comprehensive Cancer Center Innsbruck Joins Caris Life Sciences’ Precision Oncology Alliance as First International Member

Caris Life Sciences®,a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that the Comprehensive Cancer Center Innsbruck... Read More

BERG Enters Into an Agreement With Sanofi Pasteur to Identify Biomarkers of Flu Vaccine Performance

BERG, a biopharmaceutical company that merges biology with technology, today announced a new research effort with Sanofi Pasteur, the influenza vaccine global leader. Under... Read More